PROK
PROKIDNEY CORP.
Company overview
- Market capitalization
- $486.32M
- Employees
- 231
- Latest publication
- 2026-09-29
About PROKIDNEY CORP.
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 226,000USD | 893,000USD | 217,000USD | 221,000USD | 230,000USD | 76,000USD | 286,625,000USD | 171,445,000USD |
| Research Development | 33,842,000USD | 114,123,000USD | 26,821,000USD | 25,882,000USD | 27,263,000USD | 127,668,000USD | 31,250,000USD | 29,404,000USD |
| Selling General Administrative | 11,317,000USD | — | 11,935,000USD | 14,048,000USD | 14,355,000USD | — | — | — |
| General And Administrative Expenses | 11,317,000USD | — | 11,935,000USD | 14,048,000USD | 14,355,000USD | — | — | — |
| Total Operating Expenses | 45,159,000USD | 165,900,000USD | 38,756,000USD | 39,930,000USD | 41,618,000USD | 183,752,000USD | 48,973,000USD | 43,056,000USD |
| Operating Income | -44,933,000USD | — | -38,539,000USD | -39,709,000USD | -41,388,000USD | — | — | — |
| Total Other Income Expense Net | 2,312,000USD | — | 3,256,000USD | 3,592,000USD | 4,027,000USD | — | — | — |
| Interest Expense | 15,000USD | — | 2,000USD | 1,000USD | 0USD | — | — | — |
| Income Before Tax | -42,621,000USD | — | -35,283,000USD | -36,117,000USD | -37,361,000USD | — | — | — |
| Income Tax Expense | 0USD | 414,000USD | 560,000USD | 848,000USD | 591,000USD | — | — | — |
| Net Income | -42,621,000USD | -151,198,000USD | -35,843,000USD | -36,965,000USD | -37,952,000USD | -163,933,000USD | -43,395,000USD | -38,522,000USD |
| Source | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 893,000USD | 76,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Research Development | 114,123,000USD | 127,668,000USD | 106,707,000USD | 82,070,000USD | 46,255,000USD | 21,042,000USD | 75,221,000USD |
| Selling General Administrative | 51,777,000USD | 56,084,000USD | 44,815,000USD | 70,937,000USD | 8,855,000USD | 5,668,000USD | 4,159,000USD |
| General And Administrative Expenses | 51,777,000USD | 56,084,000USD | — | — | — | — | — |
| Total Operating Expenses | 165,900,000USD | 183,752,000USD | 151,522,000USD | 153,007,000USD | 55,110,000USD | 27,024,000USD | 79,380,000USD |
| Operating Income | -165,007,000USD | -183,676,000USD | -151,522,000USD | -153,007,000USD | -55,110,000USD | -27,024,000USD | -79,380,000USD |
| Total Other Income Expense Net | 13,809,000USD | 19,743,000USD | 22,071,000USD | 5,768,000USD | 2,000USD | 43,000USD | 126,000USD |
| Interest Expense | 4,000USD | 9,000USD | 12,000USD | 215,000USD | 2,000USD | 43,000USD | 0USD |
| Income Before Tax | -151,198,000USD | -163,933,000USD | -129,451,000USD | -147,239,000USD | -55,108,000USD | -26,981,000USD | -79,254,000USD |
| Income Tax Expense | 414,000USD | -598,000USD | 5,996,000USD | 896,000USD | 38,000USD | -232,000USD | 361,000USD |
| Net Income | -151,612,000USD | -163,335,000USD | -35,468,000USD | -108,032,000USD | -55,146,000USD | -26,749,000USD | -79,615,000USD |
| Cost Of Revenue | — | — | 3,169,000USD | 3,036,000USD | 1,984,000USD | — | — |
| Gross Profit | — | — | -3,169,000USD | -3,036,000USD | -1,984,000USD | — | — |
| Selling And Marketing Expenses | — | — | 1,062,000USD | — | — | 314,000USD | — |
| Interest Income | — | — | 21,205,000USD | 5,983,000USD | 2,000USD | 43,000USD | — |
| Net Interest Income | — | — | 21,194,000USD | 5,768,000USD | 2,000USD | 43,000USD | — |
| Tax Provision | — | — | 1,943,000USD | 896,000USD | 38,000USD | -232,000USD | — |
| Net Income From Continuing Ops | — | — | -138,296,000USD | -148,135,000USD | -55,146,000USD | -26,749,000USD | — |
| Ebit | — | — | -129,439,000USD | -147,024,000USD | -55,108,000USD | -27,024,000USD | -19,159,000USD |
| Ebitda | — | — | -125,586,000USD | -143,988,000USD | -53,124,000USD | -26,060,000USD | -18,292,000USD |
| Depreciation And Amortization | — | — | 3,853,000USD | 3,036,000USD | 1,984,000USD | 964,000USD | 867,000USD |
| Reconciled Depreciation | — | — | 3,498,000USD | 3,036,000USD | 1,984,000USD | 964,000USD | — |
| Minority Interest | — | — | 102,042,000USD | 40,103,000USD | 0USD | — | — |
| Non Operating Income Net Other | — | — | — | 5,983,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -188,238,000USD | -55,146,000USD | -26,749,000USD | -79,615,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 292,784,000USD | 335,574,000USD | 351,608,000USD | 372,133,000USD | 406,061,000USD | 441,073,000USD | 474,793,000USD | 499,163,000USD |
| Cash And Equivalents | 101,895,000USD | 108,537,000USD | 95,323,000USD | 84,940,000USD | 97,805,000USD | 99,120,000USD | 108,088,000USD | 214,508,000USD |
| Total Current Assets | 234,902,000USD | 280,679,000USD | 299,989,000USD | 324,440,000USD | 359,662,000USD | 395,884,000USD | 430,225,000USD | 450,262,000USD |
| Other Current Assets | 1,794,000USD | 2,804,000USD | 110,000USD | 546,000USD | 62,000USD | 80,000USD | 1,031,000USD | 0USD |
| Total Liabilities | 29,680,000USD | 34,781,000USD | 33,270,000USD | 32,680,000USD | 36,084,000USD | 39,436,000USD | 31,325,000USD | 26,797,000USD |
| Total Current Liabilities | 25,931,000USD | 30,742,000USD | 29,063,000USD | 28,262,000USD | 32,808,000USD | 36,217,000USD | 25,181,000USD | 20,589,000USD |
| Other Current Liabilities | 22,231,000USD | 28,731,000USD | 26,068,000USD | 24,916,000USD | 27,572,000USD | 31,137,000USD | 21,264,000USD | 15,109,000USD |
| Total Stockholder Equity | -1,023,783,000USD | -1,011,197,000USD | -1,008,020,000USD | -1,002,500,000USD | -998,553,000USD | -994,954,000USD | -979,712,000USD | -972,371,000USD |
| Total Equity Including Noncontrolling Interest | 263,104,000USD | 300,793,000USD | 318,338,000USD | 339,453,000USD | 369,977,000USD | 401,637,000USD | 443,468,000USD | 472,366,000USD |
| Property Plant Equipment Net | 57,813,000USD | 54,821,000USD | 51,557,000USD | 47,620,000USD | 46,314,000USD | 45,091,000USD | 44,458,000USD | 48,779,000USD |
| Accounts Payable | 2,592,000USD | 940,000USD | 1,942,000USD | 2,443,000USD | 3,122,000USD | 3,633,000USD | 2,850,000USD | 2,933,000USD |
| Short Term Debt | 1,091,000USD | 1,054,000USD | 973,000USD | 896,000USD | 840,000USD | 740,000USD | 1,032,000USD | 988,000USD |
| Retained Earnings | -1,289,872,000USD | -1,269,835,000USD | -1,250,604,000USD | -1,234,135,000USD | -1,217,583,000USD | -1,200,849,000USD | -1,179,571,000USD | -1,161,661,000USD |
| Accumulated Other Comprehensive Income | -53,000USD | 56,000USD | 74,000USD | 30,000USD | 75,000USD | 130,000USD | 321,000USD | -6,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 335,574,000USD | 441,073,000USD | 420,552,000USD | 517,996,000USD | 251,200,501USD | 16,700,000USD | 19,607,000USD |
| Cash And Equivalents | 108,537,000USD | 99,120,000USD | 60,649,000USD | 490,252,000USD | 440,488USD | — | — |
| Total Current Assets | 280,679,000USD | 395,884,000USD | 374,146,000USD | 504,719,000USD | 944,677USD | 5,585,000USD | 15,424,000USD |
| Other Current Assets | 2,804,000USD | 80,000USD | 9,000USD | 1,384,000USD | — | 1,007,000USD | 198,000USD |
| Total Liabilities | 34,781,000USD | 39,436,000USD | 29,216,000USD | 13,057,000USD | 9,579,796USD | — | — |
| Total Current Liabilities | 30,742,000USD | 36,217,000USD | 25,038,000USD | 10,873,000USD | 1,879,796USD | 5,502,000USD | 2,714,000USD |
| Other Current Liabilities | 28,731,000USD | 31,137,000USD | 17,665,000USD | 7,336,000USD | — | — | — |
| Total Stockholder Equity | -1,011,197,000USD | -994,954,000USD | -1,103,396,000USD | -1,096,616,000USD | -8,387,619USD | 9,864,000USD | 15,883,000USD |
| Total Equity Including Noncontrolling Interest | 300,793,000USD | 401,637,000USD | 391,336,000USD | 504,939,000USD | 241,620,705USD | — | — |
| Property Plant Equipment Net | 54,821,000USD | 45,091,000USD | 46,259,000USD | 12,993,000USD | — | 10,473,000USD | 3,326,000USD |
| Accounts Payable | 940,000USD | 3,633,000USD | 5,098,000USD | 3,044,000USD | 5,000USD | 781,000USD | 480,000USD |
| Short Term Debt | 1,054,000USD | 740,000USD | 751,000USD | 458,000USD | — | 225,000USD | 102,000USD |
| Retained Earnings | -1,269,835,000USD | -1,200,849,000USD | -1,139,663,000USD | -1,104,116,000USD | -8,388,308USD | -106,364,000USD | -79,615,000USD |
| Accumulated Other Comprehensive Income | 56,000USD | 130,000USD | 130,000USD | — | — | 0USD | 0USD |
| Intangible Assets | — | — | — | — | — | 642USD | 857,000USD |
| Total Liab | — | — | — | — | — | 6,836,000USD | 3,724,000USD |
| Other Current Liab | — | — | — | — | — | 4,496,000USD | 2,132,000USD |
| Common Stock | — | — | — | — | — | 116,228,000USD | 95,498,000USD |
| Capital Stock | — | — | — | — | — | 116,228,000USD | — |
| Good Will | — | — | — | — | — | 641,358USD | — |
| Cash | — | — | — | — | — | 4,578,000USD | 15,226,000USD |
| Cash And Short Term Investments | — | — | — | — | — | 4,578,000USD | 15,226,000USD |
| Net Debt | — | — | — | — | — | -3,019,000USD | -14,114,000USD |
| Short Long Term Debt Total | — | — | — | — | — | 1,559,000USD | 1,112,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | 11,630,000USD | — |
| Common Stock Shares Outstanding | — | — | — | — | — | 186,500,000shares | 78,526,027shares |
| Non Current Assets Total | — | — | — | — | — | 11,115,000USD | 4,183,000USD |
| Non Current Liabilities Total | — | — | — | — | — | 1,334,000USD | 1,010,000USD |
| Net Working Capital | — | — | — | — | — | 83,000USD | — |
| Net Tangible Assets | — | — | — | — | — | 9,222,000USD | 15,026,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,334,000USD | 1,010,000USD |
| Unclassified Equity | — | — | — | — | — | -116,228,000USD | — |
| Non Currrent Assets Other | — | — | — | — | — | — | -4,183USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 1,658,000USD | 1,837,000USD | 4,738,000USD | 3,065,000USD | 1,600,000USD | 5,432,000USD | 3,858,000USD | 2,372,000USD |
| Stock Based Compensation | 4,945,000USD | 5,703,000USD | — | — | 6,416,000USD | — | — | — |
| Change To Liabilities | -5,957,000USD | — | — | — | -5,902,000USD | — | — | — |
| Change In Working Capital | -5,348,000USD | 757,000USD | — | — | 418,000USD | — | — | — |
| Operating Cash Flow | -41,684,000USD | — | — | — | -29,592,000USD | — | — | — |
| Capital Expenditures | -3,785,000USD | -5,752,000USD | — | — | -1,135,000USD | — | — | — |
| Net Investments | 38,612,000USD | — | — | — | 29,424,000USD | — | — | — |
| Investing Cash Flow | 34,827,000USD | — | — | — | 28,289,000USD | — | — | — |
| Net Debt Issuance | -3,000USD | — | — | — | -12,000USD | — | — | — |
| Unclassified Financing Cash Flow | 218,000USD | -17,140,000USD | — | — | — | — | — | — |
| Financing Cash Flow | 215,000USD | — | — | — | -12,000USD | — | — | — |
| Change In Cash | -6,642,000USD | 13,214,000USD | -3,797,000USD | -14,180,000USD | -1,315,000USD | 38,471,000USD | 47,439,000USD | 153,859,000USD |
| End Cash Flow | 101,895,000USD | — | 95,323,000USD | 84,940,000USD | 97,805,000USD | 99,120,000USD | 108,088,000USD | 214,508,000USD |
| Net Income | — | -40,852,000USD | -35,283,000USD | -36,117,000USD | — | -163,933,000USD | -43,395,000USD | -38,522,000USD |
| Other Non Cash Items | — | 42,000USD | — | — | — | — | — | — |
| Change To Account Receivables | — | 110,000USD | — | — | — | — | — | — |
| Total Cash From Operating Activities | — | -32,513,000USD | — | — | — | — | — | — |
| Free Cash Flow | — | -38,265,000USD | — | — | — | — | — | — |
| Investments | — | 15,630,000USD | — | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | 28,093,000USD | — | — | — | — | — | — |
| Net Borrowings | — | -5,000USD | — | — | — | — | — | — |
| Total Cash From Financing Activities | — | 17,634,000USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | — | 17,145,000USD | — | — | — | — | — | — |
| Begin Period Cash Flow | — | 95,323,000USD | — | — | — | — | — | — |
| End Period Cash Flow | — | 108,537,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | 12,463,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | 17,634,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | 5,752,000USD | — | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | DisclosurePreliminary | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Depreciation | 6,575,000USD | 5,432,000USD | 3,853,000USD | 3,036,000USD | 1,984,000USD | 964,000USD | 867USD |
| Stock Based Compensation | 25,336,000USD | 29,372,000USD | 30,846,000USD | 74,469,000USD | 699,000USD | 730,000USD | 498USD |
| Change To Liabilities | -5,919,000USD | 11,592,000USD | 11,639,000USD | 494,000USD | 7,868,000USD | 683,000USD | 1,204,000USD |
| Change In Working Capital | -39,000USD | 5,028,000USD | 18,049,000USD | -6,459,000USD | 2,164,000USD | -126,000USD | -115USD |
| Operating Cash Flow | -120,117,000USD | -126,351,000USD | -90,069,000USD | -77,089,000USD | — | — | — |
| Capital Expenditures | -15,196,000USD | -29,509,000USD | -34,197,000USD | -1,846,000USD | -5,192,000USD | -5,456,000USD | -1,305USD |
| Net Investments | 100,946,000USD | 49,923,000USD | -295,786,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | 18,215,000USD | — | — | 108,000USD | 5,191,999USD | 5,348,000USD | — |
| Investing Cash Flow | 103,965,000USD | 20,414,000USD | -329,983,000USD | -1,738,000USD | — | — | — |
| Net Debt Issuance | -26,000USD | -54,000USD | -52,000USD | -32,000USD | — | — | — |
| Net Common Stock Issuance | 0USD | 0USD | -9,499,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | 25,595,000USD | 144,462,000USD | — | 548,553,000USD | — | — | — |
| Financing Cash Flow | 25,569,000USD | 144,408,000USD | -9,551,000USD | 548,521,000USD | — | — | — |
| Change In Cash | 9,417,000USD | 38,471,000USD | -429,603,000USD | 469,694,000USD | 15,980,000USD | -10,648,000USD | 15,226USD |
| End Cash Flow | 108,537,000USD | 99,120,000USD | 60,649,000USD | 490,252,000USD | — | — | — |
| Net Income | — | — | — | — | -55,146,000USD | -26,749,000USD | -79,615USD |
| Other Non Cash Items | — | — | — | — | 4,662,000USD | 604USD | 1,559USD |
| Total Cash From Operating Activities | — | — | — | — | -50,299,000USD | -25,181,000USD | -76,806USD |
| Free Cash Flow | — | — | — | — | -55,491,000USD | -30,637,000USD | -78,111USD |
| Investments | — | — | — | — | -5,191,000USD | -5,456,000USD | — |
| Total Cashflows From Investing Activities | — | — | — | — | -5,191,000USD | -5,456,000USD | -2,968USD |
| Net Borrowings | — | — | — | — | -30,000USD | -11,000USD | -11,000USD |
| Total Cash From Financing Activities | — | — | — | — | 71,470,000USD | 19,989,000USD | 20,000USD |
| Sale Purchase Of Stock | — | — | — | — | 0USD | — | — |
| Begin Period Cash Flow | — | — | — | — | 4,578,000USD | 15,226,000USD | — |
| End Period Cash Flow | — | — | — | — | 20,558,000USD | 4,578,000USD | 15,226USD |
| Other Cashflows From Investing Activities | — | — | — | — | 1USD | 108,000USD | 108,000USD |
| Other Cashflows From Financing Activities | — | — | — | — | 71,500,000USD | 20,000,000USD | 20,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -4,662,000USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 4,738,000USD | 3,065,000USD | 3,858,000USD | 2,372,000USD | 2,707,000USD | 1,702,000USD | 2,245,000USD | — |
| Stock Based Compensation | 19,633,000USD | 12,957,000USD | 22,424,000USD | 15,489,000USD | 37,216,000USD | 24,222,000USD | 65,529,000USD | — |
| Change To Liabilities | -8,075,000USD | -8,126,000USD | -114,000USD | -5,838,000USD | 7,774,000USD | 12,430,000USD | -39,000USD | 5,733,242USD |
| Change In Working Capital | -686,000USD | -1,450,000USD | -9,871,000USD | -11,957,000USD | 13,483,000USD | 14,968,000USD | -5,540,000USD | 5,733,242USD |
| Operating Cash Flow | -87,604,000USD | -61,008,000USD | -102,180,000USD | -72,939,000USD | -64,685,000USD | -40,908,000USD | -61,328,000USD | -582,942USD |
| Capital Expenditures | -9,444,000USD | -4,247,000USD | -4,000,000USD | -1,596,000USD | -32,625,000USD | -4,686,000USD | -1,540,000USD | — |
| Net Investments | 85,316,000USD | 51,101,000USD | 9,334,000USD | 88,565,000USD | -201,514,000USD | -201,079,000USD | — | — |
| Investing Cash Flow | 75,872,000USD | 46,854,000USD | 5,334,000USD | 86,969,000USD | -234,139,000USD | -205,765,000USD | -1,432,000USD | — |
| Net Debt Issuance | -21,000USD | -26,000USD | -40,000USD | -26,000USD | -39,000USD | -26,000USD | -24,000USD | — |
| Unclassified Financing Cash Flow | 7,956,000USD | — | 144,325,000USD | 139,855,000USD | — | — | 548,553,000USD | — |
| Financing Cash Flow | 7,935,000USD | -26,000USD | 144,285,000USD | 139,829,000USD | -39,000USD | -26,000USD | 548,529,000USD | 250,000USD |
| Change In Cash | -3,797,000USD | -14,180,000USD | 47,439,000USD | 153,859,000USD | -298,863,000USD | -246,699,000USD | 485,769,000USD | -332,942USD |
| End Cash Flow | 95,323,000USD | 84,940,000USD | 108,088,000USD | 214,508,000USD | 191,389,000USD | 243,553,000USD | 506,327,000USD | 107,546USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 108,000USD | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.